Keeping the engine bay clean is not just a matter of cosmetic appeal; it is a significant aspect of vehicle maintenance that ...

Q2 FY 2026 Company Highlights. Net revenues increased 16.3% to a record $18.9 million in Q2 FY 2026, from $16.3 million in the second quarter of the prior fiscal year, led by an 1 ...

Azurity Pharmaceuticals, Inc. announced that ARYNTA™ (lisdexamfetamine dimesylate) Oral Solution will be available mid-2026 for treating ADHD in adults and pediatric patients 6 years and older. Arynta ...

Fourth quarter revenue grew 29% year-over-year to $953 million Strong growth of larger customers, with 603 $1 million+ ARR customers, up from 462 a year ago Launched Bits AI SRE Agent, Storage ...

The American Brain Foundation, which supports a network of leading researchers working to unlock breakthroughs in whole-brain ...